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Distribution of Urokinase-type
Plasminogen Activator Immunoreactivity in the Mouse
ABSTRACT
￿
Immunocytochemistry, using rabbit antibodies to a urokinase-type 48-Kdalton Mr
mouse plasminogen activator, showed that enzyme immunoreactivity is widely distributed in
the normal mouse. Strong staining was obtained in widely disseminated connective tissue
cells with a fibroblast-like morphology. Such cells occurred in high numbers in the lamina
propria mucosae of the gastrointestinal tract, and in moderate numbers in the connective
tissue septa of the pancreas. A few such cells were detected around the larynx, trachea, and
bronchi. Immunoreactivity also occurred in epithelial cells of the proximal and distal kidney
tubules, the ductus deferens, and in pulmonary pneumocytes . In addition, presumably
extracellular staining was seen irregularly along the basement membrane and fibrillar structures
in the lamina propria of the small and large intestines . Moreover, decidual cells of the mouse
placenta stained strongly, and a moderate staining was observed in epithelial cells of involuting
mammary glands, but not in those of noninvoluting glands . No immunoreactivity was observed
in endothelial cells.
Control experiments included absorption of the antibodies against highly-purified mouse
plasminogen activator and the corresponding proenzyme, and the finding of a good corre-
spondence between the number of immunoreactive cells and measurable enzymatic activity
determined in adjacent tissue sections. Separation by SDS PAGE followed by immunoblotting
revealed only one immunochemically stainable protein band with Mr ^-48 Kdaltons in extracts
from tissues showing immunoreactivity.
The trypsin-like serine protease plasmin degrades most pro-
teins. It is formed from the zymogen plasminogen, present in
many extracellular fluids. Plasminogen isactivatedby another
group of serine proteases (for reviews, see references 1-3). At
least two types of plasminogen-activating enzymes are pro-
duced by animal cells, differing in Mr (-70 and 50 Kdaltons,
respectively), immunological reactivity, and interaction with
other proteins (4-19). At least some plasminogen activators
are themselvesproduced as inactive proenzymes (20-23). The
process leading to generation of plasmin is thus a cascade
reaction characterized by amplification of the proteolytic
activity and regulated by enhancing and inhibitory factors (7,
9,24-26).
The chemistry of plasminogen, plasmin, and plasminogen
activation is partly clarified (9, 27, 28). The biological function
ofplasmin and the regulation of the enzyme generation is less
well understood. Clearly, plasmin plays a role in a variety of
normal and pathological processes; its thrombolytic activity
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is the most studied (2). Recent findings indicate that the Mr
-70 Walton type of plasminogen activator (often designated
tissue-type plasminogen activator) is a key enzyme in this
process (29-31). Much attention has also been directed toward
a possible role of plasmin in tissue degradation under normal
and pathological conditions, e.g., involution ofthe mammary
gland, inflammation, arthritis, and invasive growth of troph-
oblasts and cancer cells (3, 5, 32-41, 59-62). In most of these
cases, the plasminogen activators involved seem to be of the
Mr -50-kdalton type (often designated the urokinase-type). A
role for plasmin in various other biological processes, e.g., cell
migration (42, 43) and conversion of prohormones to hor-
mones (44) has also been proposed.
Little or no information is available about the identities of
cells in the intact organism producing the two types of plas-
minogen activating enzymes. Both types are produced by a
variety of cultured cell types, derived from normal as well as
neoplastic tissue (6, 10, 15, 22, 26, 32-35, 43-45). It is
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are always representative of the cells in the intact organism.
Enzyme histochemical studies have been performed using an
agarose overlay technique with plasminogen-rich fibrin (7, 8,
46-48). This method often has shortcomings, however, related
to a low degree of resolution, a lack of distinction between
the two types ofactivators, the occurrence of inactive proen-
zymes of the plasminogen activators, and the interference of
inhibitors of plasminogen activators and plasmin (9, 20-26).
Immunocytochemical detection of plasminogen activators
has hitherto been hampered by the fact that they are present
in cells in very low concentrations. We have previously re-
ported the derivation of rabbit antibodies against a murine
M, -48-kdalton urokinase-type plasminogen activator (13).
These antibodies do not cross-react with the Mr -70-kdalton
enzyme (13) and have now been employed for immunocyto-
chemical studies in the normal mouse.
MATERIALS AND METHODS
Materials:
￿
The following materials were obtained from the indicated
sources: Cyanogen-bromide-activated Sepharose (Pharmacia, Inc., Uppsala,
Sweden); swine IgG anti-rabbit immunoglobulins and peroxidase-antiperoxi-
dase complex (Dakopatts, Copenhagen, Denmark); Millipore nitrocellulose
paper GSWP 000 10 (Millipore, Molsheim, France); urokinase (Leo Pharma-
ceutical, Ballerup, Denmark). All other materials were those described previ-
ously (10, 13, 18, 19, 20, 22, 49, 53), or of the best commercially available
grade.
Animals:
￿
Female and male BALB/c mice, 6-10 wk old, were anesthe-
tized with diethylether and perfusion-fixed with cold (4°C) 0.01 M sodium
phosphate buffer, pH 7.4, containing 0.14 M NaCl (PBS), followed by a cold
(4°C) 4% (wt/vol) paraformaldehyde solution in 0.1 M sodium phosphate
buffer, pH 7.4. In typical experiments, 20 ml ofPBS and an equal amount of
the fixative were used. In addition, tissue specimens were obtained from the
placenta ofpregnant BALB/c mice (19-20d ofpregnancy) and from mammary
glands of lactating mice deprived of their litters for 4 d after 5 d lactation, or
from mice lactating for 9 d. Tissue used for enzyme assay and electroblotting
was removed from animals perfused with 20 ml of PBS, after diethyl ether
anesthesia.
Tissue Treatments:
￿
Specimensfrom animals perfused with paraform-
aldehyde were cut into 1-2-mm cubes and postfixed overnight (typically, 16 h)
at 4°C. This was followed by a 24-h rinsing in 0.1 M sodium phosphatebuffer,
pH 7.3, containing 20% sucrose. The tissue-cubes were then frozen in melting
Freon-22, sectioned at4-8 tam on a cryostatat -20°C, and the sectionsmounted
on chromealum-gelatin-coated slides.
Specimens from the stomach (oxyntic and antropyloric mucosa) ofanimals
perfusedwith 20 ml ofPBS were flat-mounted on cardboard, frozen in melting
Freon-22, and sectioned horizontally in a cryostat at -20°C. Alternating
sections were cut at 40- and 5-tam thickness. The 5-tam sections were stained
with haematoxylin and eosin for identification ofmorphology and depthwithin
the mucosa, and the 40-tam sections were individually collected in small test-
tubes and kept frozen at -20°C for extraction and enzyme assay.
Extracts from frozen tissue samples of freshly PBS-perfused tissue were
prepared as described (33) with 0.1 M Tris/HCI, pH 8.1, containing 0.5% (wt/
vol) Triton X-100, 10 Al per mg wet tissue weight. The samples were homoge-
nized and centrifuged (4,000 g) at 4°C for 10 min.
Antibodies:
￿
Antibodies against highly-purified 48-Kdalton M murine
plasminogen activator (MPA48)' were produced by immunization of rabbits,
as described (13). The IgG fraction was purified by sodium sulphate precipita-
tion and DEAE-Sephadex ion exchange chromatography (63). The IgG was
further purified in one of two ways: (a) absorption against a glutaraldehyde
polymer of murine proteins (50). The glutaraldehyde polymer was prepared
from a mixture ofconditionedmedium from mouse sarcoma-virustransformed
plasminogen activator-producing 3T3 cells (3T3/MSV-LO) depleted of plas-
minogen activator by three passages through a 4-aminobenzamidine amino-
dodecyl cellulose column (49); conditioned medium from murine embryonal
fibroblasts(10); and normal mouse serum. All threeparts were further depleted
of MPA48 by being passed through a column ofanti-MPA48 IgG coupled to
'Abbreviations used in this paper:
￿
MPA48, 48 kdalton M, murine
plasminogen activator; TBS, Tris-buffered saline.
Sepharose 4B. The glutaraldehyde polymer was prepared from 30 ml protein
solution in 0.2 M sodium acetate buffer, pH 5.0, containing BSA (25 mg/ml)
by slowly adding 6 ml of 2.5% glutaraldehyde (wt/vol). The IgG preparations
were applied to and eluted from the polymer in PBS at 4°C (50). (b) Affinity
chromatography on a column containing purified MPA48 coupled to CNBr-
activated Sepharose 4B. The column (bed volume 2 ml) contained 2 mg of
purified enzyme (fraction IV, see reference 49), and was equilibrated with 0.1
M Tris HCI, pH 8.1, 0.1% (wt/vol) Triton X-100. The IgG was applied in this
buffer (20 ml), and the column washed with 20 ml 0.1 M Tris HCl, pH 8.1,
0.7 M NaCl, 0.1% wt/vol Triton X-100. Elution (l4 ml/h) was carried out
with 0.05 M glycine HCI, pH 2.5, 0.4 M NaCI, 0.01 % Triton, and the emerging
fractions were immediately mixed with sufficient Tris HCl-bufferto re-establish
a pH of8. l .
Preimmune and nonimmune IgG was purified and absorbed in the same
way. The purified IgG preparationswere screened for their ability tostain spots
ofMPA48 and its proenzyme form (pro-MPA48) (20) with an immunocyto-
chemical model system (51), in which spots of the enzyme preparations were
applied toWhatman No. I paper(Whatman Laboratory Products, Inc., Clifton,
NJ).
lmmunocytochemistry: Cryostat sections or paper models were
soaked in 0.05 M Tris HCI, pH 7.4, with 0.15 M NaCl and I% (wt/vol) Triton
X-100 (TBS-Triton) for 15 min, exposed to l% (wt/vol) human serumalbumin
or 10% normal goat serum in TBS-Triton for 30 min at room temperature,
briefly rinsed in TBS-Triton, and exposed to varying concentrations of anti-
bodies purified as described above. For both affinity-purified antibodies and
antibodies cross-absorbed against irrelevant mouse proteins, optimal IgG con-
centrations for staining were found to be 5-10 Ag/ml (dilutions performed in
TBS with 0.25% BSA) using 20 h ofincubation at 4°C followed by 2 h ofre-
equilibration at room temperature. The site of antigen-antibody reaction was
revealed withtheperoxidase-antiperoxidase method ofStemberger,asdescribed
(52, 53). Peroxidase activity was demonstrated by the diaminobenzidine-H202
method (52) and sections were occasionally counterstained lightly with hae-
matoxylin.
In some experiments, endogenous peroxidase activity of mouse tissues was
quenched by exposure to methanol/H202 priorto immunocytochemical stain-
ing (53). This treatment somewhat compromised, but did not totally inhibit,
immunocytochemical staining, and was therefore not used routinely. Whenever
employed, adjacent sections not exposed to the methanol/H202 reagent were
analyzed in parallel.
Controls were those recommended by Stemberger (52) and included (a)
omission ofeither the first, second, or third layer ofantiserum; (b) substitution
oftheprimary antibodiesby preimmune or nonimmune IgG (atconcentrations
of 5-50 Ag/ml), or by control hyperimmune sera (antigastrin serum 4652,
antisomatostatin serum R 213/3); (c) absorption of the primary antibodies
against varying concentrations (4.2-63.0 kU/ml), of highly-purified pro-
MPA48 or MPA48 (20, 49). The pro-MPA48 used for antibody absorption
showed one Coomassie Bluestainable band correspondingto M -48 Kdaltons
afterpolyacrylamide gel electrophoresis under reducing as well as nonreducing
conditions(20) (detection limit for possible contaminating proteins was --5%).
The MPA48 for absorption studies was generated from the pro-MPA by
incubation with catalytic amounts of plasmin (20). Further controls for estab-
lishing that the staining was due to pro-MPA48/MPA48 present in the tissue
included: (d) comparisons among the distribution of immunocytochemically
stained structures and levels ofextractable enzyme activity in various organs;
(e) comparisons between the topography of immunocytochemically stained
cells and enzyme activity in the mouse stomach using horizontal sections; and
(/) separation ofextracted tissueproteinson gradientSDS PAGEelectroblotting
to nitrocellulose paper and immunocytochemical staining of the blots (see
below).
Plasminogen ActivatorAssay:
￿
The plasminogen activator content
in tissue samples was determined by a modification of the '2°Wabeled fibrin
plate assay, in which catalytic amounts ofplasmin were added to allow for the
simultaneous determination of pro-MPA48 and MPA48 (20). Each assay well
contained0.5 mlof0.1 M Tris HCI, pH 8.1, 0.1% Triton X-100, 0.25% gelatin,
1 tag human glu-plasminogen, and 7 ng human plasmin. In parallel assays, 0.25
tag affinity-purified anti-MPA48 IgG (13) was added. This completely inhibited
the enzymatic activity of purified pro-MPA48 and MPA48, although it did not
inhibit M, -70-Kdalton murine plasminogen activator (13). Pro-MPA48/
MPA48 in the samples was calculated as that part of the activity that was
inhibited by the anti-MPA48 IgG. In all assays, a highly purified pro-MPA48
standard preparation (20, 0.5-2 U/ml, see reference 10 for definition of I U
MPA48) was used forcalibration. The same preparation wasused as an internal
standard to check for the possible inhibition of the assay by inhibitors of
plasmin and/or plasminogen activators (20). In some tissue extracts, a strong
inhibition of the internal standard was observed under these conditions. For
the assays described in Table I, the assay conditions were therefore modified so
that the incubation period was 20 h and the concentration of plasmin was 660
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895pg/ml. This modification allowed a higher dilution ofthe samples before the
assay (5,000-200,000-fold) and resulted in the inhibition being nondetectable
or moderate in all cases (see legend for Table I). In the 20-h assays, a pro-
MPA48 standard attheconcentrations 21-210 mU/mlwasusedforcalibration.
Electrophoresis and lmmunoblotting: SDS PAGE was per-
formed in a stacking system using slab gels with a gradient of6-16% (wt/vol)
polyacrylamide (10) and a potential difference of 60 V, for 16-18 h. Following
SDS PAGE oftissue extracts, the proteins were transferred electrophoretically
(10 V, 250 mA) from the polyacrylamide gel onto nitrocellulose paper(54) for
16 h, in a buffer containing 0.125 M Tris, pH 8.6, 0.19 M glycine, 20% (vol/
vol) methanol and 0.1 % (wt/vol) SDS, or alternatively a 50 mM phosphate
buffer, pH 7.4. The nitrocellulose paper was air-dried, fixed in 4% (wt/vol)
paraformaldehyde solution in 0.1 M sodium phosphate buffer, pH 7.4, and
washed in TBS-Triton for 2 x 10 min. Longitudinal lanes were cut out and
some lanes were then stained with amido black and destained in 10% acetic
acid. Otherlanes wereincubated for30 min with TBS-Triton containing human
serum albumin (10 mg/ml). The paper was then washed 2 x 15 min in TBS-
Triton and incubated overnight (4*C) with anti-MPA48 IgG, control IgG, or
BSA, all diluted in TBS-Triton containing 0.25% (wt/vol) BSA. After temper-
ature re-equilibration for 1 h, lanes were washed in TBS-Triton 3 x 20 min
and incubated for 30 min with swine anti-rabbit immunoglobulins (diluted
1:30 in PBS with normal swine IgG (4 mg/ml)). The lanes were further washed
3 x 10 min in TBS-Triton and incubated with peroxidase-antiperoxidase
complex (diluted 1 :70 in TBS) for 30 min. Before the final peroxidase reaction
(52), lanes were extensively washed in the following order. TBS-Triton (5 min),
8 M urea in TBS-Triton (l h at 37*C, while shaken), TBS-Triton (2 x 5 min),
and 0.05 M Tris-HCI, pH 7.6 (2 x 5 min). All incubations and washing
procedures were performed at room temperature unless otherwise stated.
In each gel, the following mixture of marker proteins was electrophoreseá
and transferred by electroblotting: rabbitphosphorylase (M 94 Kdaltons), BSA
(M, 67 Kdaltons), ovalbumin (M 43 Kdaltons), carbonic anhydrase (M, 30
Kdaltons), soybean trypsin inhibitor (M, 20.1 Kdaltons), and a-lactalbumin
(M, 14.4 Kdaltons).
RESULTS
Cytochemical Paper Models
When applied to paper models containing spots of pro-
MPA48 or MPA48, both affinity-purified antibodies and
antibodies absorbed against mouse proteins produced strong
staining at IgG concentrations varying between 1-10 fig/ml.
The antibodies were equally effective in staining both pro-
MPA48 and MPA48, but did not stain BSA, plasminogen,
and plasmin. Unfixed models as well as models fixed for 1 h
in 4% paraformaldehyde were stained equally well. Absorp-
tion of the antibodies (at 5 Ag IgG per ml with 21 KU per ml
of pro-MPA48 or MPA48) abolished staining of the paper
models. Control IgG and control hyperimmune sera did not
stain the pro-MPA48 or MPA48 spots.
Tissue Distribution
In tissue sections, both affinity-purified antibodies and anti-
bodies absorbed against a mixture ofmouse proteins depleted
of MPA48 produced exactly the same pattern of staining. In
all localizations to be reported below, both types of antibodies
were used.
Gastrointestinal Tract
MPA48-like immunoreactivity occurred in a widespread
system of connective tissue cells distributed in the lamina
propria mucosae along the entire gastrointestinal tract. Other
layers of the gut wall were devoid ofimmunoreactive cells. In
the oxyntic gland area of the stomach, immunoreactive cells
occurred in the uppermost portion of the lamina propria
mucosae, surrounding the neck of the glands (Fig. 1). Deeper
parts of the lamina propria were devoid of immunoreactive
cells. The cells displayed a fibroblast-like morphology and
were often spindle-shaped or triangular, occasionally with
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TABLE I
Enzyme Activity of MPA48 in
Murine Tissues
Tissues were removed, weighed, and extracted with 0.1 M Tris HCI con-
taining 0.5% Triton X-100. Extracts from five mice were pooled and assayed
by the "'I-labeled fibrin plate method for 20 h in the presence of plasmin-
ogen and catalytic amounts of plasmin. This method determines the com-
bined content of MPA48 and its inactive proenzyme (pro-MPA48). Extracts
with purified pro-MPA added as an internal standard were assayed in
parallel. No inhibition of the internal standard was observed except with
the extract of duodenum. Numbers are corrected for this inhibition, which
was 28%. Anti-MPA48 IgG (affinity purified) was added in a concentration
(0.5 ug/ml) that completely inhibited the activity of purified MPA48 and
pro-MPA48. The MPA48 activity was calculated as that part of the activity
that was inhibited by the antibodies. All determinations were performed in
quadruplicate. Means ± standard errors on the means are indicated.
Milligrams of wet weight of tissue.
' Superficial layer of antral mucosa.
s Plasminogen activator activity in the uppermost 300 Am of the mucosa,
determined by adding results of assays of tissue sections performed as
described in the legend to Fig. 1 .
Superficial layer of oxyntic mucosa.
blunt processes extending towards the surface or neck epithe-
lial cells. Similar cells were detected in the antropyloric mu-
cosa ofthe stomach. In this region, however, the cells extended
deeper between the pyloric glands, sometimes reaching the
muscularis mucosae. The antropyloric cells were more elon-
gated than the oxyntic cells and frequently gave off long
processes that came into close contact with the epithelialcells.
In the stomach, most or all immunoreactivity was localized
to the cytoplasm ofthe fibroblast-likecells, with little evidence
of extracellular localization. No immunoreactivity was de-
tected in the nuclei ofthe cells.
In the small intestines, much immunoreactivity was distrib-
uted in the connective tissue core of the villi, and smaller
amounts occurred in the lamina propria surrounding the
crypts (Fig. 2). Most immunoreactivity was associated with
slender fibrillar structures and with the basement membrane.
Without the aid ofelectron microscopy it was not possible to
decide whether the long fibrillar structures represented fibro-
blastoid cells. A fair amount ofthe immunoreactivity detected
in the small intestines, particularly that associated with the
basement membrane, may represent extracellular stores of
pro-MPA48 or MPA48.
In the colon, immunoreactive fibroblast-likecells morpho-
logically similar to those observed in the stomach were again
encountered (Fig. 3). Typically, the colonic cells were located
superficially in the lamina propria mucosae beneath the sur-
face epithelium, but were occasionally seen to extend down
between the colonic crypts. The basement membrane under
the colonic epithelium also displayed strong immunoreactiv-
ity. The staining was often patchy, but sometimes followed
the contour of the entire basement membrane down to the
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￿
Distribution of MPA48 enzyme activity (a) and immu-
noreactivity (b) in mouse oxyntic mucosa . As described in the text,
horizontal 40-,um cryostat sections were cut and assayed for enzyme
activity (top) . The distribution of this activity agrees closely with the
distribution of MPA48 immunoreactivity as shown by immunocy-
tochemistry (middle) . Thus, as shown by the diagram the upper 180
jm of the mucosa contains abundant enzyme activity as well as
FIGURE 2 Mouse duodenum stained with antiserum to MPA48 .
Reaction product occurs in fibrillar structures in the villi cores and
alongthe basement membrane . In this region, it is difficult to decide
whether the stained material is intracellular or not .
bottom of the crypts . Again, it is likely that this staining
represents extracellular material . It is impossible to decide by
light microscopy whether it was the basement membrane
proper or a structure closely associated with it that was stained .
The colonic fibroblast-like cells were of a more rounded shape
than those detected in the stomach and contained abundant
immunoreactivity in their cytoplasm with unstained nuclei .
They were typically positioned close to the overlying epithe-
lium .
Few and scattered immunoreactive cells were also observed
in the connective tissue septa separating the pancreatic lob-
ules. Again, the cells were fibroblast-like and displayed a
triangular shape, occasionally with long processes . No other
pancreatic structure (ducts, acini, islets, blood vessels) was
stained.
Thus, in the gastrointestinal tract, immunoreactiveMPA48
is confined to cells that, from their morphology and position
in the connective tissue stroma are reminiscent offibroblasts .
It is important to point out, however, that most gastrointes-
immunocytochemically stained cells, whereas deeper portions con-
tain only trace amounts of enzyme activity and no positive cells . In
the bottom panel an adjacent section has been stained with MPA48-
preabsorbed anti-MPA48 . Note absence of staining of the superfi-
cially located fibroblastoid cells . Enzyme activity was determined
by the . .I-labeled fibrin plate assay with incubation for 1 h at 37°C .
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897FIGURE 3 Mouse colonic mucosa stained with anti-MPA48 (top
and middle) or with MPA48-preabsorbed anti-MPA48 (bottom) . The
immunoreactive fibroblastoid cells (marked with straight arrows,
top) occur in great number in the most superficial part of the
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tinal fibroblasts are nonreactive. In the small and large intes-
tines, but not in the stomach or pancreas, part ofthe MPA48-
like immunoreactivity may be localized to the extracellular
compartment, particularly in association with the basement
membrane .
Other Organs
Structures containing MPA48-like immunoreactivity could
not be detected in the brain, pituitary gland, or liver . In the
lung, virtually all pneumocytes were weakly to moderately
stained, producing a typical reticulated staining pattern (Fig .
4) . In addition, the connective tissue surrounding the cartilage
occurring in the larger bronchi and, particularly, in the trachea
and larynx, contained scattered, strongly immunoreactive,
fibroblast-like cells . The tracheal and bronchial epithelium,
glands, cartilage, and most of the connective tissue stroma
were unstained. The staining ofthe pneumocytes was depend-
ent upon effective perfusion-fixation of the lung through the
pulmonary arteries.
Very intense and widespread staining was observed in the
kidneys . Portions of both proximal and distal tubules and
medullary rays were stained . In the tubules (Fig . 5), the
staining was distinctly granular . Immunopositive granules
were often seen apically in the tubule cells, and occasionally
also surrounded the nuclei . Few or no immunoreactive gran-
ules were seen in the basal portion of the cells . In some
tubules, immunoreactivity was also seen on the luminal sur-
faces of the epithelial cells . In the urinary bladder, immuno-
reactive cells occurred in the epithelium, situated below the
surface epithelial cells and displaying a granular staining
pattern (Fig. 6) . The epithelial cells of the vas deferens also
displayed strong immunoreactivity. Here the immunostaining
was confined to apical granules of the stereociliated cells in a
fashion suggesting active secretion into the lumen . In the
lumen, weak to moderate immunoreactivity was detected,
often associated with spermatozoa (Fig . 7).
In the placenta in late pregnancy (19-21 d), numerous
strongly immunoreactive cells were detected in the decidua
(Fig . 8). In the mammary glands of mice that had been
lactating for 9 d, no immunoreactivity could be detected. If,
however, the mice had been deprived of their litters after 5 d
of lactation and then left for 4 d before sacrifice, weak to
moderate immunoreactivity could be detected in intracyto-
plasmic vacuoles of the involuting gland cells (Fig . 9). In all
organs investigated, no staining was found in the endothelial
cells of any vessel .
Control Experiments
Staining controls, including the use of up to 50 jg/ml
nonimmune orpreimmune IgG and unrelated hyperimmune
sera, were negative, as were experiments in which the various
antibody layers were deleted. Absorption of the anti-MPA48
antibodies against highly-purified pro-MPA48 or MPA48
colonic mucosa . Unspecific peroxidase activity occurs in granulo-
cytes scattered all over the mucosa (curved arrows) . In tangential
sections (middle), the fibroblastoid cells are seen to surround the
apical portions of the colonic crypts . Occasionally, as in this picture,
staining associated with the basement membrane is also observed .
Preabsorption of the antiserum with MPA48 (bottom) prevents
staining of the fibroblastoid cells and basement membrane, whereas
the unspecific peroxidase activity of the granulocytes persists .FIGURE 4
￿
Mouse lung stained with anti-MPA48 (left) or with MPA48-preabsorbed anti-MPA48 (right) . Specific staining occurs in
the pneumocytes and is completely abolished in the preabsorbed control . Scattered erythrocytes display pseudoperoxidase
activity.
FIGURE 5
￿
Mouse kidney stained with anti-MPA48 (left) or with MPA48-preabsorbed anti-MPA48 (right) . Note the occurrence of
specific staining in part of the tubules.
completely abolished staining ofall structures reported above .
In all specimens, erythrocytes and granulocytes were the only
cell types displaying significant endogenous peroxidase activ-
ity. As noted above, blocking ofendogenous peroxidase activ-
ity was associated with some decrease in specific immuno-
reactivity . However, after such blocking treatment, both
erythrocytes and granulocytes were completely unstained.
The distribution of immunoreactive cells was compared
with enzyme activity in tissue extracts (Table I). The MPA48
activity was calculated as that part of the total plasminogen
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899activating activity that was inhibited by antibodies against
MPA48 . For extracts where the MPA48 activity constituted
a large part of the total activity, this led to rather precise
determinations, whereas the determinations for extracts in
which MPA48 constituted a small part of the activity showed
FIGURE 6 Mouse urinary bladder stained with anti-MPA48 . Note
the presence of MPA48 immunoreactivity in cytoplasmic granules
of some, but not all, epithelial cells (arrows) .
great statistical uncertainty . In the tissues for which fairly
precise enzyme measurements were obtained, there was a
good correspondence between enzyme activity and immu-
noreactivity . Thus, in descending order both in terms of
number of cells stained and in enzyme activity, came the
superficial mucosa of stomach, vas deferens, kidney, lung,
and placenta .
Within the gastric mucosa, the topographic distribution of
immunoreactive cells and of enzyme activity also corre-
sponded . Thus, in the oxyntic mucosa, where the immuno-
reactive fibroblast-like cells were oriented very superficially,
enzyme activity was also located superficially (see Fig. 1). In
the antropyloric mucosa, in which the immunoreactive cells
extended deeper between the glands, the enzyme activity also
extended deeper (data not shown) .
Extracts of superficial sections of oxyntic mucosa were
separated bySDS polyacrylamide gradient gel electrophoresis,
electroblotted, and the nitrocellulose replicas stained immu-
nocytochemically. Only one immunoreactive band, corre-
sponding in electrophoretic mobility to pure MPA48, was
observed (under nonreducing conditions, pro-MPA48 and
MPA48 display similar mobilities in this system [20; Fig .
10]) . In deeper sections of oxyntic mucosa (not containing
immunoreactive cells), no immunoreactive band was detected
on the nitrocellulose replicas . Similar analysis of extracts of
lung, vas deferens, placenta, and kidney also disclosed one
single band with the same electrophoretic mobility as pro-
MPA48 and MPA48 (data not shown) .
FIGURE 7
￿
Mouse vas deferens stained with anti-MPA48 (left) or with MPA48-preabsorbed anti-MPA48 (right) . Note the presence
of immunoreactive MPA48 in apical granules of the stereociliated epithelial cells (straight arrows) and weaker immunoreactivity
in luminal material surrounding spermàtozoa . Nonspecific pseudoperoxidase activity is displayed by erythrocytes (curved arrows) .
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￿
Mouse placenta (day 19 of pregnancy) stained with anti-
MPA48 . Scattered cells situated at the border of the decidua and
the uterine wall display strong immunoreactivity .
FIGURE 9
￿
Mouse involuting breast . Specific MPA48 immunoreac-
tivity occurs in intracellular vacuoles of degenerating gland cells
(arrows) .
FIGURE 10
￿
Immunoblotting analysis ofMPA48 from Triton X-100
extracts of fundus (1) and of purified pro-MPA48 (2) . Whole fundus
was extracted with 0 .1 M Tris-HCI, pH 8.1, containing 0.5% Triton
X-100, and 350 jLg of proteins were applied to each of 4 lanes (1,
a-d) . Highly purified pro-MPA48 were applied to each of four other
lanes (21 kunits to lane 2a and 105 U to lane 2, b-d) . Following
SIDS polyacrylamide gel electrophoresis (10), the proteins were
electrophoretically transferred onto nitrocellulose paper. The paper
was cut longitudinally and the lanes were either stained with amido
black (a) or by the PAP method using anti-MPA48 IgG (5 gg/ml) (b),
anti-MPA48 IgG (5 kg/ml) preabsorbed with pro-MPA48 (21 kunits/
ml) (c), or nonimmune IgG (5,ug/ml) (d) .
DISCUSSION
We have utilized polyclonal rabbit antibodies to highly puri-
fied MPA48 for immunocytochemistry. Our staining and
absorption controls clearly demonstrate that nonimmuno-
logical binding of the purified IgG preparations to tissue
components can be excluded. The results of these control
experiments direct our considerations towards the possible
presence of contaminating antibodies or cross-reactive anti-
gens. The enzyme preparations used for absorption controls
were electrophoretically pure (detection limit for contaminat-
ing proteins was -5%) . It is therefore unlikely, although not
completely excluded, that the staining was due to the presence
of contaminating antibodies. The possible staining of cross-
reacting antigens in the various cell types and tissue compart-
ments could not be evaluated by the absorption experiments,
but a number of other findings indicate that the staining was
most likely due to the presence ofpro-MPA48/MPA48 . Com-
parisons between the distributions of enzyme activity and
immunocytochemically-stained cells in the different organs
correlate well . Both pro-MPA48 and MPA48 are detected by
the enzymatic assay used (20), and our paper cytochemical
models demonstrate that the antibodies employed bind
equally well to pro-MPA48 and MPA48 . Furthermore, pre-
treatment of the paper models with the fixative used (4%
paraformaldehyde) showed that this treatment did not com-
promise the antigenicity . We also find that the results of our
studies on the topography of extractable enzyme activity in
the oxyntic mucosa (see Fig . 1) provide convincing evidence
that the staining, at least in this area, in reality corresponds
to authentic pro-MPA48/MPA48 .
By extraction with Triton X-100 followed by SDS PAGE
and immunoblotting, we have demonstrated, in a number of
tissues, the selective staining of a protein band with an elec-
trophoretic mobility in SDS PAGE identical to that of pro-
MPA48/MPA48 .To diminish the possibility ofa hypothetical
cross-reactive antigen not being transferred in the electroblot-
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without SDS, yielding identical results. However, a hypothet-
ical cross-reacting antigen couldstill be unseen, if it remained
tissue-bound after Triton-solubilization, or if it had a molec-
ular weight too large to pass into the polyacrylamide gel. The
consistency of our staining results and our biochemical find-
ings, however, argues against this possibility. We thus find
that, although not completelyconclusive, it is very likely that
the staining demonstrated in this study was due to authentic
pro-MPA48/MPA48.
However, pro-MPA48 or MPA48 may be present in other
cells or organs than those found in this study, in amounts
below our detection limit. Furthermore, our results only
determine the presence of a certain amount of pro-MPA48
or MPA48 in cells orextracellular space at thetime offixation,
and they do not necessarily reflect the site or amount of
production of the enzyme.
We have previously reported the immunocytochemical lo-
calization of the human 52-kdalton Mr plasminogen activator
in the cytoplasm of cultured glioblastoma cells grown in
culture (55). In the present study, immunoreactivity was also
mainly located in the cytoplasm. This contrasts to an earlier
report of plasminogen activator immunoreactivity primarily
associated with the cell membrane in an electron microscop-
ical study (56). This report, however, lacks details about the
purity of the enzyme preparation used to elicit the antibodies,
and apart from negative results with nonimmune serum, cites
no control experiments verifying the specificity ofthe staining.
Moreover, the staining conditions used presumably did not
permit intracytoplasmic penetration of the antibodies. It
should be noted that the distribution of the MPA48 immu-
noreactivity in the cytoplasm is different in differentcell types;
immunoreactivity is distinctlygranular in kidney tubular cells
and epithelial cells of the vas deferens, reticulated in pneu-
mocytes, and more diffusely distributed in the MPA48-im-
munoreactive fibroblast-like cell type and the decidual cells.
Localization ofplasminogen activators was previously done
by histochemical studies, seldom distinguishing between the
two types of plasminogen activators. The original studies
demonstrated plasminogen-dependent fibrinolysis primarily
in the venous endothelium of a number ofhuman organs (47,
48). Furthermore, lysis was seen over renal tubules and lung
tissue.
The 50-Kdalton type plasminogen activator is found in
large quantities in urine (49). The demonstration of a great
amount of MPA48 immunoreactivity in the kidney tubule
cellssuggests that the urine plasminogen activator is excreted
or synthesized by these cells. Our results from mammary
glands agree with previous findings and lend support to the
hypothesis that the urokinase-type plasminogen activator
plays a role in postlactational involution (32). The finding of
MPA48 immunoreactivity in what appears to be secretory
granules in the ductus deferens correlates with a report on
plasminogen activators in semen (57).
It is noteworthy that no MPA48 immunoreactivity was
found in endothelial cells of any vessels. The plasminogen
activator found histochemically in these cells (47, 48), at least
in human tissue, is of the 70-kdalton Mr type (17, 31). These
findings support the hypothesis that the type of plasminogen
activator playing a natural role in thrombolysis is of the 70-
kdalton Mr type (tissue-type) and not of the 50-kdalton Mr
(urokinase-type), although the latter type of plasminogen
activator has been widely used as a thrombolytic agent (58).
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The possible role ofplasminogen activatorin the alimentary
canal still remains to be investigated. It is tempting to link
the localization beneath the epithelium in these organs with
the continuousrenewal of this epithelium.
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